Scarica l'app Stockscreener
22.84
2.15%
0.48
Pre-mercato:
23.59
0.75
+3.28%
Pacira Biosciences Inc Borsa (PCRX) Ultime notizie
Pacira BioSciences, Inc. (NASDAQ:PCRX) Receives $24.50 Average Price Target from Analysts - Defense World
PCRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & ... - The Bakersfield Californian
PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - GlobeNewswire Inc.
ROSEN, A LEADING LAW FIRM, Encourages Pacira BioSciences, - GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel - The Bakersfield Californian
ROSEN, A LEADING LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PCRX - GlobeNewswire Inc.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Pacira Biosciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesPCRX - PR Newswire
Pacira Pharmaceuticals Announces Leadership Changes and Plan Amendment - TipRanks
Pacira BioSciences Strengthens Executive Leadership Team with Two Key Appointments - GlobeNewswire
Pacira BioSciences Strengthens Leadership Team with Two Strategic Executive Appointments - StockTitan
Pacira BioSciences, Inc. Class Action: Levi & Korsinsky Reminds - GuruFocus.com
Pacira BioSciences, Inc. Class Action: Levi & Korsinsky Reminds Pacira Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025PCRX - Victoria Advocate
PCRX Investors Have Opportunity to Lead Pacira BioSciences, Inc. Securities Fraud Lawsuit - Longview News-Journal
PCRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Pacira BioSciences, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm for More InformationPCRX - Marketscreener.com
Assenagon Asset Management S.A. Trims Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX) - MarketBeat
Assenagon Asset Management S.A. Sells 101,021 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World
Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Zacks Research Analysts Increase Earnings Estimates for PCRX - Defense World
PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira - Kilgore News Herald
Lowey Dannenberg Notifies Pacira Biosciences, Inc. - GlobeNewswire
PCRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Pacira BioSciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
Zacks Research Has Positive Outlook of PCRX FY2024 Earnings - MarketBeat
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 14, 2025 in Pacira LawsuitPCRX - Morningstar
PCRX Investors Have Opportunity to Lead Pacira BioSciences, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Kilgore News Herald
(PCRX) On The My Stocks Page - Stock Traders Daily
Investors in Pacira BioSciences, Inc. Should Contact Levi & - GlobeNewswire
PACIRA BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire
Millennium Management LLC's Strategic Acquisition of Pacira BioS - GuruFocus.com
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages - GlobeNewswire
The Gross Law Firm Notifies Shareholders of Pacira - GlobeNewswire
PACIRA BIOSCIENCES SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc.PCRX - Business Wire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira - Marketscreener.com
PCRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira - GlobeNewswire
Stockholder Notice: Robbins LLP Informs Stockholders of the Pacira BioSciences, Inc. Class Action Lawsuit - PR Newswire
PCRX Stock Rises 11% on Upbeat Q4 Preliminary Product Sales - MSN
Pacira Patent Void Surprised Investors to Big Selloff, Suit Says - Bloomberg Law
Pacira BioSciences (NASDAQ:PCRX) Earns Sector Perform Rating from Royal Bank of Canada - MarketBeat
SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
2025-01-14 | PCRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:PCRX | Press Release - Stockhouse Publishing
Pacira BioSciences (NASDAQ:PCRX) Given New $30.00 Price Target at Needham & Company LLC - Defense World
PCRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
PCRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Rosen Law Firm Urges Pacira BioSciences, Inc. (NASDAQ: PCRX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - The Bakersfield Californian
2025-01-13 | PCRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:PCRX | Press Release - Stockhouse Publishing
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors - GlobeNewswire
6 Analysts Assess Pacira BioSciences: What You Need To Know - Benzinga
Pacira Pharmaceuticals, Inc. Provides Revenue Guidance for the Fourth Quarter and Full-Year of 2014 - Marketscreener.com
Pacira BioSciences (NASDAQ:PCRX) Shares Gap Up – Time to Buy? - Defense World
Pacira BioSciences (NASDAQ:PCRX) Shares Gap UpWhat's Next? - MarketBeat
Pacira BioSciences, Inc. Reports Preliminary Unaudited Revenue Results for the Year Ended December 31, 2024 - Marketscreener.com
Pacira Announces New Five-Year Objectives to Accelerate - GlobeNewswire
2.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):